Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · January 28, 2024

Safety and Efficacy of Reduced-Dose vs Full-Dose Alteplase for the Treatment of Patients With Acute Pulmonary Embolism

Critical Care Medicine


Additional Info

Critical Care Medicine
Safety and Efficacy of Reduced-Dose Versus Full-Dose Alteplase for Acute Pulmonary Embolism: A Multicenter Observational Comparative Effectiveness Study
Crit. Care Med. 2024 Jan 02;[EPub Ahead of Print], R Melamed, DM Tierney, R Xia, CS Brown, KC Mara, M Lillyblad, A Sidebottom, BM Wiley, I Khapov, O Gajic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading